The objective of this study is to conduct a randomized cross-over dietary intervention in adult women who are overweight or obese to compare how yogurt and a control food affect biomarkers of inflammation and intestinal health.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
40
Low-fat flavored yogurt
Low-fat flavored soy pudding
Department of Food Science, Babcock Hall
Madison, Wisconsin, United States
Change in Th17 proportion
Change in proportions of circulating Th17 cells (change in control vs. change in yogurt)
Time frame: Baseline, Week 4, Week 8, Week 12
Change in Treg proportion
Change in proportion of circulating Treg cells (change in control vs. change in yogurt)
Time frame: Baseline, Week 4, Week 8, Week 12
Change in Treg subpopulation
Change in proportion of circulating Treg subpopulation (FoxP3+ IL-10+) (change in control vs. change in yogurt)
Time frame: Baseline, Week 4, Week 8, Week 12
Change in Th17 subpopulation (IL-17A+ TNFα+)
Change in proportion of circulating Th17 subpopulation (IL-17A+ TNFα+) (change in control vs. change in yogurt)
Time frame: Baseline, Week 4, Week 8, Week 12
Change in Th17 subpopulation (IL-17A+ IFNδ+)
Change in proportion of circulating Th17 subpopulation (IL-17A+ IFNδ+) (change in control vs. change in yogurt)
Time frame: Baseline, Week 4, Week 8, Week 12
Change in Th17 subpopulation (IL-17A+ IL-22+)
Change in proportion of circulating Th17 subpopulation (IL-17A+ IL-22+) (change in control vs. change in yogurt)
Time frame: Baseline, Week 4, Week 8, Week 12
Change in Th17 subpopulation (IL-17A+ FoxP3+)
Change in proportion of circulating Th17 subpopulation (IL-17A+ FoxP3+) (change in control vs. change in yogurt)
Time frame: Baseline, Week 4, Week 8, Week 12
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Change in Th17 subpopulation (IL-17A+ IL-10+)
Change in proportion of circulating Th17 subpopulation (IL-17A+ IL-10+) (change in control vs. change in yogurt)
Time frame: Baseline, Week 4, Week 8, Week 12
Change in plasma tumor necrosis factor alpha (TNF-alpha)
Change in fasting plasma TNF-alpha (change in control vs. change in yogurt)
Time frame: Baseline, Week 4, Week 8, Week 12
Change in plasma interferon gamma (IFN-gamma)
Change in fasting plasma IFN-gamma (change in control vs. change in yogurt)
Time frame: Baseline, Week 4, Week 8, Week 12
Change in plasma interleukin-6 (IL-6)
Change in fasting plasma IL-6 (change in control vs. change in yogurt)
Time frame: Baseline, Week 4, Week 8, Week 12
Change in plasma interleukin-17A (IL-17A)
Change in fasting plasma IL-17A (change in control vs. change in yogurt)
Time frame: Baseline, Week 4, Week 8, Week 12
Change in plasma interleukin-4
Change in fasting plasma IL-4 (change in control vs. change in yogurt)
Time frame: Baseline, Week 4, Week 8, Week 12
Change in plasma interleukin-22 (IL-22)
Change in fasting plasma IL-22 (change in control vs. change in yogurt)
Time frame: Baseline, Week 4, Week 8, Week 12
Change in plasma interleukin-10 (IL-10)
Change in fasting plasma IL-10 (change in control vs. change in yogurt)
Time frame: Baseline, Week 4, Week 8, Week 12
Change in plasma transforming growth factor beta (TGF-beta)
Change in fasting plasma TGF-beta (change in control vs. change in yogurt)
Time frame: Baseline, Week 4, Week 8, Week 12
Change in retinoic acid receptor-related orphan nuclear receptor gamma T (RORgammaT) expression
Change in fasting plasma RORgammaT expression (change in control vs. change in yogurt)
Time frame: Baseline, Week 4, Week 8, Week 12
Change in Forkhead box P3 (FoxP3) expression
Change in fasting FoxP3 expression (change in control vs. change in yogurt)
Time frame: Baseline, Week 4, Week 8, Week 12
Change in fecal calprotectin
Change in fecal calprotectin (change in control vs. change in yogurt)
Time frame: Baseline, Week 4, Week 8, Week 12
Change in fecal tumor necrosis factor alpha (TNF-alpha)
Change in fecal TNF-alpha (change in control vs. change in yogurt)
Time frame: Baseline, Week 4, Week 8, Week 12
Change in fecal interleukin 1 alpha (IL-1alpha)
Change in fecal IL-1alpha (change in control vs. change in yogurt)
Time frame: Baseline, Week 4, Week 8, Week 12
Change in fecal interleukin 1beta (IL-1beta)
Change in fecal IL-1beta (change in control vs. change in yogurt)
Time frame: Baseline, Week 4, Week 8, Week 12
Change in fecal interleukin-6 (IL-6)
Change in fecal IL-6 (change in control vs. change in yogurt)
Time frame: Baseline, Week 4, Week 8, Week 12
Change in fecal interleukin-17A (IL-17A)
Change in fecal IL-17A (change in control vs. change in yogurt)
Time frame: Baseline, Week 4, Week 8, Week 12